Thyroid ocular myopathy.
Hodes BL, Shoch DE.
Trans Am Ophthalmol Soc. 1979;77:80-103.
Extra-ocular muscle cells from patients with Graves' ophthalmopathy secrete alpha (CXCL10) and beta (CCL2) chemokines under the influence of cytokines that are modulated by PPARgamma.
Antonelli A, Ferrari SM, Corrado A, Franceschini SS, Gelmini S, Ferrannini E, Fallahi P.
Autoimmun Rev. 2014 Nov;13(11):1160-6. doi: 10.1016/j.autrev.2014.08.025. Epub 2014 Aug 27.
Antibodies targeting the calcium binding skeletal muscle protein calsequestrin are specific markers of ophthalmopathy and sensitive indicators of ocular myopathy in patients with Graves' disease.
Gopinath B, Musselman R, Beard N, El-Kaissi S, Tani J, Adams CL, Wall JR.
Clin Exp Immunol. 2006 Jul;145(1):56-62. doi: 10.1111/j.1365-2249.2006.03110.x.
Treatment of thyroid ocular myopathy with adjustable and nonadjustable suture strabismus surgery.
Kraus DJ, Bullock JD.
Trans Am Ophthalmol Soc. 1993;91:67-79; discussion 79-84.
Avoiding surgery for thyroid eye disease.
Meyer PA.
Eye (Lond). 2006 Oct;20(10):1171-7. doi: 10.1038/sj.eye.6702393.
[Myasthenia, from the internist's point of view].
Eymard B.
Rev Med Interne. 2014 Jul;35(7):421-9. doi: 10.1016/j.revmed.2013.08.013. Epub 2013 Oct 7.
Novel case of ocular neuromyotonia associated with thyroid-related orbitopathy and literature review.
Giardina AS, Slagle WS, Greene AM, Musick AN, Eckermann DR.
Optom Vis Sci. 2012 Dec;89(12):e124-34. doi: 10.1097/OPX.0b013e31827731bf.
Clinical and imaging clues to the diagnosis and follow-up of ptosis and ophthalmoparesis.
Keene KR, Kan HE, van der Meeren S, Verbist BM, Tannemaat MR, Beenakker JM, Verschuuren JJGM.
J Cachexia Sarcopenia Muscle. 2022 Dec;13(6):2820-2834. doi: 10.1002/jcsm.13089. Epub 2022 Sep 29.
Cloning and characterization of the novel thyroid and eye muscle shared protein G2s: autoantibodies against G2s are closely associated with ophthalmopathy in patients with Graves' hyperthyroidism.
Gunji K, De Bellis A, Li AW, Yamada M, Kubota S, Ackrell B, Wengrowicz S, Bellastella A, Bizzarro A, Sinisi A, Wall JR.
J Clin Endocrinol Metab. 2000 Apr;85(4):1641-7. doi: 10.1210/jcem.85.4.6553.
Thyroid-associated ophthalmopathy: clinical features, pathogenesis, and management.
Yamada M, Li AW, Wall JR.
Crit Rev Clin Lab Sci. 2000 Dec;37(6):523-49. doi: 10.1080/10408360091174303.
